• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

Recent Advances in the Study of 2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid (CAS: 1150644-39-5)

2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid (CAS: 1150644-39-5) is a pyrimidine derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its role as a key intermediate in the synthesis of bioactive compounds, particularly in the context of kinase inhibitors and antimicrobial agents. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential therapeutic applications.

The compound's unique structural features, including the ethylamino and carboxylic acid functional groups, make it a versatile building block for the design of novel pharmaceutical agents. Recent synthetic methodologies have focused on optimizing the yield and purity of 2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid, with particular emphasis on green chemistry approaches to reduce environmental impact. Advances in catalytic systems and solvent-free reactions have been reported to enhance the efficiency of its production.

In terms of biological activity, 2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid has shown promising results in preliminary screenings against various kinase targets. Kinases play a critical role in cell signaling pathways, and their dysregulation is associated with numerous diseases, including cancer and inflammatory disorders. The compound's ability to modulate kinase activity has been investigated through in vitro and in silico studies, with some derivatives demonstrating selective inhibition of specific kinase isoforms. These findings suggest its potential as a scaffold for the development of targeted therapies.

Additionally, recent research has explored the antimicrobial properties of 2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid and its derivatives. Studies have reported moderate to high activity against a range of bacterial and fungal pathogens, with mechanisms of action involving interference with nucleic acid synthesis and cell wall integrity. Structure-activity relationship (SAR) studies have been conducted to identify key structural modifications that enhance antimicrobial efficacy while minimizing toxicity.

Despite these promising findings, challenges remain in the translation of 2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid into clinical applications. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further optimization and preclinical testing. Collaborative efforts between academic and industrial researchers are essential to overcome these hurdles and unlock the full therapeutic potential of this compound.

In conclusion, 2-(Ethylamino)-6-methylpyrimidine-4-carboxylic acid (CAS: 1150644-39-5) represents a valuable chemical entity with diverse applications in drug discovery. Ongoing research continues to uncover its potential as a kinase inhibitor and antimicrobial agent, paving the way for the development of novel therapeutics. Future studies should focus on refining its pharmacological profile and exploring its utility in combination therapies and personalized medicine approaches.

• 933759-45-6(2-(Dimethylamino)pyrimidine-4-carboxylic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)